2020-11-16T19:56:12-06:00 2019-12-31 271728945 PKF O'CONNOR DAVIES LLP 665 FIFTH AVENUE NEW YORK NY 10022 990 2019-01-01 133859563 THE ZACHARY & ELIZABETH M FISHER CENTER FOR ALZHEIMER'S RESEARCH FOUNDATION ZACH 2129151328 110 EAST 42ND STREET 16TH FLOOR NEW YORK NY 10017 BARRY R SLOANE CHAIRMAN & TREASURER 2129151328 2020-11-16 1 GARRETT M HIGGINS P00543209 2122862600 2020-11-12 68.175.34.111 2020-11-16 18:10:40 ES P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 B29914CEB47F2C50F9800CDE5B5AE22990D509AB 2019 2021-01-29 14:40:06Z ALZHEIMER'S RESEARCH FDNFISHER CTR BARRY R SLOANE 110 EAST 42ND STREET 16TH FLOOR NEW YORK NY 10017 14062429 0 X WWW.ALZINFO.ORG X 1995 NY THE FOUNDATION FUNDS RESEARCH INTO THE CAUSE, CARE, AND CURE OF ALZHEIMER'S DISEASE AT THE ZACHARY AND ELIZABETH M. FISHER CENTER FOR RESEARCH ON ALZHEIMER'S DISEASE AT THE ROCKEFELLER UNIVERSITY IN NEW YORK THAT WAS UNDER THE DIRECTION OF NOBEL LAUREATE DR. PAUL GREENGARD WHOSE FINDINGS HAVE BEEN THE BASIS FOR MUCH OF TODAY'S ALZHEIMER'S INVESTIGATIONS. 14 13 5 15 0 0 5365421 6868429 0 0 -136890 2253116 670 3000 5229201 9124545 2820707 3430534 0 0 1096670 742488 0 0 196694 519254 501354 4436631 4674376 792570 4450169 26210287 31521960 3544564 2890733 22665723 28631227 X 1. THE ZACHARY AND ELIZABETH M. FISHER ALZHEIMER'S RESEARCH FOUNDATION IS DEDICATED TO ATTACKING THE SCOURGE OF ALZHEIMER'S DISEASE THROUGH A 3PRONGED ASSAULT FOCUSED ON UNDERSTANDING THE CAUSE OF ALZHEIMER'S DISEASE (AD), IMPROVING THE CARE OF PEOPLE LIVING WITH THE DISEASE TO ENHANCE THEIR QUALITY OF LIFE AND THAT OF THEIR CAREGIVERS AND FAMILIES, AND FINDING A CURE. 0 0 3306534 3305534 A MAJORITY OF OUR GRANT FUNDING GOES TO THE ZACHARY AND ELIZABETH M. FISHER CENTER FOR RESEARCH ON ALZHEIMER'S DISEASE (THE FISHER CENTER LAB) AT THE ROCKEFELLER UNIVERSITY IN NEW YORK, FOR NEUROLOGICAL RESEARCH INTO THE CAUSE OF ALZHEIMER'S AND POTENTIAL NEW PHARMACOLIGICAL TREATMENT OPTIONS. THE LAB WAS UNDER THE DIRECTION OF NOBEL LAUREATE DR. PAUL GREENGARD UNTIL APRIL 2019. DR. GREENGARD COLLABORATED WITH SCIENTISTS NATIONALLY AND INTERNATIONALLY TO INVESTIGATE THE LATEST, MOST PROMISING RESEARCH AVAILABLE. THE COLLABORATIONS WILL CONTINUE IN HIS ABSENCE UNDER THE INTERIM LEADERSHIP OF DR. MARC FLAJOLET. THE FISHER CENTER HAS PROVIDED RESEARCHERS WORLDWIDE WITH A CONCEPTUAL FRAMEWORK FOR UNDERSTANDING THE DISEASE PROCESS AND CONTINUES TO BE AT THE FOREFRONT OF ONE DAY FINDING A CURE FOR ALZHEIMER'S DISEASE.A GRANT WAS MADE TO THE ROCKEFELLER UNIVERSITY (RU) IN 2016 TO ESTABLISH THE PAUL GREENGARD PROFESSORSHIP (ESTABLISHED IN PERPETUITY) TO RECOGNIZE DR. PAUL GREENGARD. THIS ENSURES A CONTINUED COMMITMENT TO THE OUTSTANDING RESEARCH BY THE FISHER CENTER FOR ALZHEIMER'S RESEARCH LABORATORY. THE PROFESSORSHIP IS HELD BY AN OUTSTANDING SCIENTIST AT RU WORKING IN THE FIELD OF AD. THE $5 MILLION GRANT IS PAID TO RU OVER SEVEN YEARS. 446958 THE ALZHEIMER'S INFORMATION PROGRAM PROMOTES PUBLIC DISEASE AWARENESS, EDUCATION, AND RESOURCES FOR CAREGIVERS, THROUGH MEDIA CONDUITS, SOCIAL NETWORKS, AND THE INTERNET. THE HEART OF THE PROGRAM IS THE WEBSITE, ALZINFO.ORG, WHICH IS UPDATED REGULARLY TO PROVIDE COMPREHENSIVE DATA ABOUT ALZHEIMER'S DISEASE, RECENT RESEARCH STUDIES AND FINDINGS, TREATMENTS, AND DISEASE MANAGEMENT. THE SITE HAS HAD 556,250 UNIQUE VISITORS AND OFFERS A FREE RESOURCE LOCATOR THAT IDENTIFIES DOCTORS, NURSES, GERIATRIC CAREGIVERS, HOME HEALTH AGENCIES, AND OTHER SOURCES BY ZIP CODE. OUR SCIENTISTS ANSWER QUESTIONS THROUGH AN "ASK THE EXPERTS" PORTAL ON OUR WEBSITE, AND CAREGIVERS CAN JOIN OUR SUPPORT GROUP THROUGH OUR ONLINE CAREGIVER'S CORNER. OUR 1-800-ALZINFO PHONE SYSTEM ASSISTS PEOPLE WHO DO NOT HAVE ACCESS TO THE INTERNET. OUR FREE E-NEWSLETTER, ALZHEIMER'S RESEARCH NEWS YOU CAN USE, IS THE MOST REVIEWED ALZHEIMER'S AND DEMENTIA NEWSLETTER ON THE INTERNET. OUR AWARD WINNING TRIANNUAL PRINT PUBLICATION, "PRESERVING YOUR MEMORY," CIRCULATES 52,000 COPIES PER ISSUE AND HAS REACHED 10.6 MILLION PEOPLE SINCE ITS INCEPTION. THE EDITORIAL CONTENT IS REVIEWED BY OUR SCIENTIFIC TEAM FOR ACCURACY AND VALIDITY AS IT ADDRESSES READERS AFFECTED BY THE DISEASE, WHETHER CAREGIVER OR PATIENT. IT PROVIDES INFORMATION ABOUT ALZHEIMER'S TREATMENT, CARE OPTIONS, AND NECESSARY STEPS TO TAKE AFTER RECEIVING AN ALZHEIMER'S DIAGNOSIS. 125000 125000 A GRANT WAS MADE TO THE NEW YORK UNIVERSITY SCHOOL OF MEDICINE FOR THE FISHER ALZHEIMER'S DISEASE EDUCATION AND RESOURCES PROGRAM WHERE DRS. REISBERG AND KENOWSKY EXAMINED HEALTH OUTCOMES OF THE COMPREHENSIVE, INDIVIDUALIZED, AND PATIENT-CENTERED ALZHEIMER'S MANAGEMENT PROGRAM. PRIMARY RESEARCH FOCUSED ON THE EFFECTS OF THE PROGRAM ON ANTIDEPRESSANT USAGE AND COST. DR. KENOWSKY WILL PRESENT THESE FINDINGS AT THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE IN JULY 2020. THESE RESULTS ARE UNDER EMBARGO UNTIL PRESENTED AT THE CONFERENCE. IN ADDITION, RESEARCH WAS CONDUCTED ON THE RELATIONSHIP BETWEEN BEHAVIORAL DISTURBANCES AND THE PROGRESSION OF PERSONS WITH SUBJECTIVE COGNITIVE DECLINE (SCD). 3878492 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 1 14 0 5 1 0 0 0 0 0 0 0 0 0 0 0 0 X 14 13 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AZ CT UT IL MI MO MT NJ NY NC OH PA RI TX VA WA WI CA MD X X X LUCRETIA HOLDEN 2129151328 110 EAST 42ND STREET FL 16 NEW YORK NY 10017 LUCRETIA HOLDEN EXECUTIVE DIRECTOR 40.00 X 165462 0 21946 BARRY R SLOANE CHAIRMAN/TREASURER 6.75 X X 0 0 0 HOWARD LUTNICK VICE CHAIR 0.25 X X 0 0 0 MARTIN EDELMAN VICE CHAIR 0.25 X X 0 0 0 MURRAY RUBIN SECRETARY (THRU MAR. 2019) 0.50 X X 0 0 0 DAVID HW TURNER TRUSTEETHRU 03/2019), SECRETARY (AFTER 03/2019) 1.00 X X 0 0 0 DR MANNY ALVAREZ TRUSTEE 0.25 X 0 0 0 DR E RATCLIFFE ANDERSON JR TRUSTEE 0.50 X 0 0 0 GERRY BYRNE TRUSTEE 0.50 X 0 0 0 HADLEY FISHER TRUSTEE 0.50 X 0 0 0 BETSY GOTBAUM TRUSTEE 0.50 X 0 0 0 JAMES L NEDERLANDER TRUSTEE 0.25 X 0 0 0 RICHARD J SALEM TRUSTEE 0.50 X 0 0 0 DR MOSHE SHIKE TRUSTEE 0.25 X 0 0 0 LOIS WHITMAN-HESS TRUSTEE 0.50 X 0 0 0 DR PAUL GREENGARD TRUSTEE (THRU APR. 2019) 0.50 X 0 0 0 165462 0 21946 1 0 1 0 STAYWELL COMPANY LLC 407 NORWALK STREET GREENSBORO NC 27407 MAGAZINE PUBLISHING 202910 KORN FERRY 200 PARK AVENUE NEW YORK NY 10166 ORGANIZATIONAL CONSULTING 112146 2 247000 6621429 200481 6868429 480283 480283 6710717 4937884 1772833 1772833 1772833 MISCELLANEOUS REVENUE 900099 3000 3000 3000 9124545 0 0 2256116 3405534 3405534 25000 25000 187408 95615 53698 38095 481357 245587 137924 97846 3051 1557 874 620 29721 15164 8516 6041 40951 20893 11734 8324 17465 17465 107982 107982 63291 63291 938 938 12388 4570 3481 4337 63377 1329 24819 37229 61783 61783 7591 7591 846 846 11119 11119 SUBSCRIPTIONS - REPRESE 139931 139931 MISCELLANEOUS 5662 1460 4202 8981 8981 4674376 3878492 599190 196694 2375934 4148305 8568653 9016767 755410 517434 5457 5107 0 6979 12806 9941 3711 2865 14501122 17821738 0 2765 26210287 31521960 171203 79748 3373361 2810985 3544564 2890733 X 22284312 28326376 381411 304851 22665723 28631227 26210287 31521960 X 4450169 1379889 138211 -2765 X X 0 1 X 1 0 X 3248678 4377975 6064311 5365421 6868429 25924814 3248678 4377975 6064311 5365421 6868429 25924814 1632136 24292678 491655 350202 331693 324830 480283 1978663 1336 1790 670 3000 6796 27910273 0.87040 0.84650 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS - 2016 AMOUNT: $ 1,336. 2017 AMOUNT: $ 1,790. 2018 AMOUNT: $ 670. 2019 AMOUNT: $ 3,000. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 12806 9941 2865 2865 X 10880165 1379889 300811 138211 1818911 9061254 63291 63291 9124545 4914661 300811 2765 303576 4611085 63291 63291 4674376 PART X, LINE 2: ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES - THE FOUNDATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. MANAGEMENT HAS DETERMINED THAT THE FOUNDATION HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION OR DISCLOSURE. THE FOUNDATION IS NO LONGER SUBJECT TO EXAMINATIONS BY THE APPLICABLE TAXING JURISDICTIONS FOR TAX YEARS PRIOR TO 2016. PART XI, LINE 2D - OTHER ADJUSTMENTS: PRIOR YEAR ADJUSTMENTS 138,211. PART XII, LINE 2D - OTHER ADJUSTMENTS: WRITE OFF OF UNCOLLECTIBLE CONTRIBUTION 2,765. 1 EUROPE 0 0 GRANTS 25000 0 0 0 0 0 0 25000 0 25000 EUROPE RESEARCH 25000 WIRE TRANSFER 1 0 0 0 0 0 0 0 PART I, LINE 2: A GRANT WAS GIVEN TO THE BRAIN AND SPINE IMAGING INSTITUTE TO CARRYOUT RESEARCH BY BENOIT DELATOUR, MARC DHENAIN, PATRICE DUBREUIL, AND OLIVIER HERMINE TO INVESTIGATE WHETHER STRUCTURE OF AMYLOID PROTEINS ARE CHANGED PARTICULARLY IF PROTEINS AGGREGATES, WHICH ARE TOXIC FOR SYNAPSES ARE DECREASED. IN THIS HYPOTHESIS, MASITINIB MAY DECREASE PROTEASE RELEASE BY MAST CELLS, WHICH MAY BE RESPONSIBLE OF GENERATION OF PROTEINS AGGREGATE, AND TEST WHETHER MASITINIB IS ABLE TO BLOCK LESIONS SPREADING AFTER PRIONS LIKE PROTEINS INOCULATION. THIS PROJECT WILL REVEAL ROLE OF MAST CELL AND KINASES IN THE PATHOPHYSIOLOGY OF ALZHEIMER DISEASE. A BETTER UNDERSTANDING OF ITS MECHANISMS OF DEFINE THE BEST STRATEGY TO IMPROVE ALZHEIMER DISEASE. PROVIDE THE FISHER CENTER FOUNDATION WITH AN MONTH REPORT ON THE PROGRESS OF THEIR INVESTIGATIONS AND A FINAL REPORT AT THE END OF THE AGREEMENT. PART I, LINE 3: THE ORGANIZATION USES THE ACCRUAL METHOD OF ACCOUNTING TO ACCOUNT FOR ITS FOREIGN EXPENDITURES. PART III ACCOUNTING METHOD: 1 THE ROCKEFELLER UNIVERSITY 1230 YORK AVENUE NEW YORK NY 10021 131624158 501(C)(3) 3000000 SEE PART IV NYU MEDICAL CENTER 550 FIRST AVENUE NEW YORK NY 10016 135562308 501(C)(3) 125000 SEE PART IV 2 0 PART I, LINE 2: THE FOUNDATION MONITORS THE USE OF GRANT FUNDS IN THE US BY RECEIVING PERIODIC PROGRESS REPORTS ON THE RESEARCH CONDUCTED AND ANY FINDINGS PUBLISHED AS A RESULT OF THIS FUNDING. THE FISHER CENTER FOR ALZHEIMER'S DISEASE RESEARCH AT THE ROCKEFELLER UNIVERSITY SUBMITS A REPORT AT EACH GENERAL BOARD MEETING WHICH IS INCORPORATED INTO THE MINUTES OF THE MEETING. THE FISHER EDUCATIONAL AND RESOURCES PROGRAM AT NYU SCHOOL OF MEDICINE REPORTS AT THE END OF THE FUNDING PERIOD IN THEIR REQUEST FOR FURTHER FUNDING ON THE PROGRESS TO DATE OF THE RESEARCH ACTIVITIES SUPPORTED BY THE FOUNDATION. THE FOUNDATION FUNDING DECISIONS ARE MADE UNDER THE SOLE AND ABSOLUTE DISCRETION OF THE BOARD PURSUANT TO A MAJORITY VOTE. A SCIENCE ADVISORY BOARD COMPRISED OF MEDICAL AND SCIENTIFIC EXPERTS IN THE FIELD OF ALZHEIMER'S DISEASE AND RELATED DISEASES ADVISES AND ASSISTS THE FOUNDATION IN CONNECTION WITH FUNDING GRANT REQUESTS. FORM 990, SCHEDULE I, PART II, COLUMN (H): PURPOSE OF GRANT THE ROCKEFELLER UNIVERSITY: GRANTS TO THE FISHER CENTER FOR ALZHEIMER'S DISEASE RESEARCH AT THE ROCKEFELLER UNIVERSITY FOR NEUROLOGICAL RESEARCH INTO THE CAUSES OF ALZHEIMER'S AND POTENTIAL NEW PHARMACOLOGICAL TREATMENT OPTIONS AND TO SUPPORT PROFESSORSHIP TO CONDUCT RESEARCH ACTIVITIES. NYU MEDICAL CENTER: NYU GRANT TO FISHER EDUCATION AND RESOURCES PROGRAM AT NY UNIVERSITY SCHOOL OF MEDICINE FOR CLINICAL RESEARCH INTO THE EFFICACY OF MEMANTINE AND COMPREHENSIVE INDIVIDUALIZED PATIENT-CENTERED MANAGEMENT OF ALZHEIMER'S DISEASE. X X X X 0 0 0 0 0 0 0 1 0 LUCRETIA HOLDEN EXECUTIVE DIRECTOR 140462 0 25000 0 0 0 2603 0 19343 0 187408 0 0 0 PART I, LINE 7 THE EXECUTIVE DIRECTOR, LUCRETIA HOLDEN, WAS AWARDED A BONUS OF $25,000 BY A UNANIMOUS VOTE OF THE COMPENSATION COMMITTEE OF THE BOARD, AND IS REPORTED ON SCHEDULE J, PART II, COLUMN B(III). CENTURY BANK SEE PART V 7135293 SEE PART V 0 FORM 990, SCHEDULE L, PART IV RESULTING FROM HIGHLY COMPETITIVE RATES OFFERED BY CENTURY BANK, THE FOUNDATION HOLDS $7,135,293 IN CERTIFICATES OF DEPOSIT AND MONEY MARKET ACCOUNT WITH CENTURY BANK, WHERE MR. BARRY SLOANE (THE FOUNDATION'S CHAIRMAN/TREASURER) SERVES AS PRESIDENT AND CEO. MR. BARRY SLOANE AND HIS FAMILY MEMBERS OWN MORE THAN 35% OF THE TOTAL COMBINED VOTING POWER OF THE CENTURY BANK. THE ENTIRE BOARD WAS MADE AWARE OF THE CONFLICT WITH MR. SLOANE BEFORE THE INVESTMENTS WERE MADE, AS WELL AS A CONTINUING DISCLOSURE AT ALL SUBSEQUENT BOARD MEETINGS. THE BOARD UNANIMOUSLY VOTED TO APPROVE THE INVESTMENTS. MR. SLOANE RECUSED HIMSELF FROM THE VOTE. X 37 200481 AVG SELLING PRICE 0 0 0 0 PART I, COLUMN (B): THE ORGANIZATION IS REPORTING THE NUMBER OF DONORS ON PART I, LINE 9, COLUMN (B). FORM 990, PART VI, SECTION B, LINE 11B THE 990 IS INITIALLY REVIEWED BY MEMBERS OF THE AUDIT COMMITTEE THAT CONSISTS OF 3 INDEPENDENT TRUSTEES. A COPY IS THEN FORWARDED ELECTRONICALLY TO ALL BOARD MEMBERS AND RELEVANT MANAGEMENT PERSONNEL FOR THEIR REVIEW AND COMMENT. ANY REQUIRED REVISIONS ARE MADE AND THE REVISED 990 IS RESUBMITTED TO ALL BOARD MEMBERS FOR FINAL REVIEW BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C THE FOUNDATION HAS A CONFLICT OF INTEREST POLICY WHICH IS ANNUALLY MONITORED REQUIRING ALL TRUSTEES TO DISCLOSE ANY POSSIBLE CONFLICT OF INTEREST VIA EMAIL RESPONSE TO THE SENIOR VICE PRESIDENT. THE FOUNDATION REQUIRES THAT ALL TRUSTEES, OFFICERS, KEY EMPLOYEES AND STAFF PERSONNEL PROMPTLY AND FULLY DISCLOSE ALL MATERIAL FACTS OF ANY ACTUAL OR POTENTIAL CONFLICT OF INTEREST THAT MAY EXIST AT THE TIME THE TRUSTEE IS APPOINTED OR STAFF PERSONNEL IS HIRED, OR AS THEY MAY ARISE WHILE THE TRUSTEE IS SERVING ON THE BOARD OR THE STAFF PERSONNEL IS EMPLOYED BY THE FOUNDATION. SUCH DISCLOSURES INVOLVING A TRANSACTION, ARRANGEMENT OR DECISION BEING CONSIDERED BY THE BOARD ARE MADE KNOWN TO ALL TRUSTEES. THE BOARD THEN DETERMINES WHETHER A CONFLICT OF INTEREST EXISTS WITH THE INTERESTED PARTY ABSTAINING FROM THE DECISION. IF IT IS DETERMINED THAT NO CONFLICT EXISTS, THEN THE BOARD VOTES ON THE TRANSACTION BUT WITH THE INTERESTED PARTY RECUSING HIMSELF FROM THE DISCUSSION AND VOTE ON SAID MATTER. FORM 990, PART VI, SECTION B, LINE 15A THE FOUNDATION HAS A COMPENSATION COMMITTEE CONSISTING OF 3 INDEPENDENT TRUSTEES TO DETERMINE THE COMPENSATION OF TOP MANAGEMENT AND KEY EMPLOYEES AT LEAST ONCE A YEAR.THE COMMITTEE IS MANDATED BY ITS CHARTER TO REVIEW EXECUTIVE AND OTHER KEY EMPLOYEE PERFORMANCE CONSISTENT WITH THE GOALS AND OBJECTIVES OF THE FOUNDATION AS DETERMINED BY THE BOARD OF TRUSTEES AND TO DETERMINE AN APPROPRIATE LEVEL OF COMPENSATION IN LIGHT OF THIS PERFORMANCE REVIEW AND USING OTHER SUBSTANTIATING DATA SURVEYS ON CURRENT COMPENSATION RATES FOR SIMILAR POSITIONS IN OTHER COMPARABLE NONPROFITS IN THE NEW YORK CITY AREA.THE COMMITTEE'S DECISION IS DOCUMENTED IN A CONTEMPORANEOUSLY WRITTEN FORMAT (COMPENSATION COMMITTEE MINUTES) INDICATING THE DATE OF THE MEETING, THE MEMBERS PRESENT, AND THE COMPARABLE DATA USED TO MAKE THE DECISION.THE COMPENSATION REVIEW PROCESS FOR THE PRESIDENT/CEO AND EXECUTIVE VICE PRESIDENT WAS LAST UNDERTAKEN IN DECEMBER 2019. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION MAKES ITS FORM 990 AND AUDITED FINANCIAL STATEMENTS AVAILABLE FOR PUBLIC INSPECTION AS REQUIRED UNDER SECTION 6104 OF THE INTERNAL REVENUE CODE BY POSTING IT ON THEIR WEBSITE AS WELL AS OTHER SIMILAR WEBSITES SUCH AS WWW.GUIDESTAR.ORG. IN ADDITION, THE FORM 990 AND AUDITED FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND OTHER POLICIES ARE AVAILABLE UPON WRITTEN REQUEST AT 110 E. 42ND STREET, FL 16, NEW YORK, NY 10017 OR BY CALLING THE ORGANIZATION DIRECTLY AT (800) 259-4636 OR (212) 915-1328. FORM 990, PART XI, LINE 9: WRITE OFF OF UNCOLLECTIBLE CONTRIBUTION -2,765. FORM 990, PART XII, LINE 2C: THE FOUNDATION HAS AN AUDIT COMMITTEE THAT IS RESPONSIBLE FOR OVERSIGHT OF THE AUDIT AND ITS FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT. THE PROCESS HAS NOT CHANGED FROM THE PREVIOUS YEAR.